Validation of an Adjusted Dosing Algorithm of Carboplatin
Condition(s):CancerLast Updated:April 3, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):CancerLast Updated:April 3, 2014Unknown status
Condition(s):Castration-resistant Prostate Cancer; MetastasisLast Updated:February 17, 2020Recruiting
Condition(s):FIGO Stage IIC-IV Ovarian Carcinoma; Fallopian Tube Carcinoma; Peritoneal CarcinomaLast Updated:January 31, 2020Completed
Condition(s):Squamous Cell Carcinoma of the Head and NeckLast Updated:February 26, 2021Recruiting
Condition(s):RetinoblastomaLast Updated:December 19, 2014Unknown status
Condition(s):Recurrent Ovarian Cancer; Platinum Sensitive Ovarian CancerLast Updated:December 8, 2016Terminated
Condition(s):Carcinoma, Non-Small-Cell Lung; Urinary Bladder NeoplasmsLast Updated:January 9, 2018Terminated
Condition(s):Glioma; Brain Neoplasms; Brain MetastasisLast Updated:September 11, 2017Terminated
Condition(s):Advanced Solid Tumor; Metastatic Solid TumorLast Updated:May 13, 2016Completed
Condition(s):Pediatric Solid TumorLast Updated:January 16, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.